PHARMANUTRA SPA (PHN.MI) Forecast, Price Target & Analyst Ratings

BIT:PHN • IT0005274094

Current stock price

67.1 EUR
-0.2 (-0.3%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PHARMANUTRA SPA (PHN.MI).

Forecast Snapshot

Consensus Price Target

Price Target
€83.98
+ 25.16% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 13, 2026
Period
Q4 / 2025
EPS Estimate
€0.63
Revenue Estimate
36.865M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€83.98
Upside
+ 25.16%
From current price of €67.10 to mean target of €83.98, Based on 7 analyst forecasts
Low
€74.74
Median
€86.70
High
€92.40

Price Target Revisions

1 Month
0.00%
3 Months
1.65%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for PHN.MI. The average price target is 83.98 EUR. This implies a price increase of 25.16% is expected in the next year compared to the current price of 67.1.
The average price target has been revised upward by 1.65% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

PHN Current Analyst RatingPHN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

PHN Historical Analyst RatingsPHN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
PHN.MI was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about PHN.MI.
In the previous month the buy percentage consensus was at a similar level.
PHN.MI was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 13, 2026
Period
Q4 / 2025
EPS Estimate
€0.63
Revenue Estimate
36.865M
Revenue Q2Q
-37.96%
EPS Q2Q
N/A
Number of Analysts
2

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
2.53%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

PHN.MI is expected to report earnings on 3/13/2026. The consensus EPS estimate for the next earnings is 0.63 EUR and the consensus revenue estimate is 36.87M EUR.
The next earnings revenue estimate has been revised upward by 2.53% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
PHN.MI revenue by date.PHN.MI revenue by date.
82.724M
21.45%		100.202M
21.13%		115.498M
15.27%		133.6M
15.67%		153.48M
14.88%		176.55M
15.03%		199.81M
13.17%		204.81M
2.50%		219.58M
7.21%		233.53M
6.35%		246.67M
5.63%		255.12M
3.43%
EBITDA
YoY % growth
PHN.MI ebitda by date.PHN.MI ebitda by date.
24.392M
20.10%		26.512M
8.69%		31.575M
19.10%		34.277M
8.56%		40.883M
19.27%		48.68M
19.07%		42.43M
-12.84%		54.022M
27.32%		57.644M
6.70%		61.165M
6.11%		64.384M
5.26%		67.301M
4.53%
EBIT
YoY % growth
PHN.MI ebit by date.PHN.MI ebit by date.
23.074M
21.95%		23.388M
1.36%		27.646M
18.21%		29.708M
7.46%		36.087M
21.47%		43.7M
21.10%		46.019M
5.31%		50.515M
9.77%		53.978M
6.86%		57.237M
6.04%		60.292M
5.34%		62.171M
3.12%
Operating Margin
PHN.MI operating margin by date.PHN.MI operating margin by date.
27.89%23.34%23.94%22.24%23.51%24.75%23.03%24.66%24.58%24.51%24.44%24.37%
EPS
YoY % growth
PHN.MI eps by date.PHN.MI eps by date.
1.56
15.55%		1.33
-14.74%		N/A
43.02%		2.03
6.55%		2.50
23.42%		3.06
22.48%		N/AN/AN/AN/AN/AN/A

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25
EPS
Q2Q % growth		0.63
Revenue
Q2Q % growth		36.865M
-37.96%
EBITDA
Q2Q % growth		7.878M
-53.82%
EBIT
Q2Q % growth		6.666M
-49.24%

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

PHN.MI Yearly Revenue VS EstimatesPHN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50M 100M 150M 200M 250M
PHN.MI Yearly EPS VS EstimatesPHN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
17.22%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
15.07%
Revenue Next 5 Year
12.06%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
20.23%
EBIT Next 5 Year
14.04%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

PHARMANUTRA SPA / PHN.MI Forecast FAQ

Can you provide the average price target for PHARMANUTRA SPA stock?

7 analysts have analysed PHN.MI and the average price target is 83.98 EUR. This implies a price increase of 25.16% is expected in the next year compared to the current price of 67.1.

Can you provide the upcoming earnings date for PHARMANUTRA SPA?

PHARMANUTRA SPA (PHN.MI) will report earnings on 2026-03-13, after the market close.

What are the consensus estimates for PHN stock next earnings?

The consensus EPS estimate for the next earnings of PHARMANUTRA SPA (PHN.MI) is 0.63 EUR and the consensus revenue estimate is 36.87M EUR.

Can you provide the consensus rating for PHARMANUTRA SPA stock?

The consensus rating for PHARMANUTRA SPA (PHN.MI) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.